Shares of Moderna MRNA were up 15.8% on Jan. 21, after the company and its partner Merck MRK announced positive median ...
We recently published 10 Big Names Leaving Wall Street Behind; 7 Are Hitting Record Highs. Moderna Inc. (NASDAQ:MRNA) was one of the worst performers on Wednesday. Moderna surged to a new 52-week high ...
Clinical Trials Arena on MSN
Moderna’s cancer vaccine plus Keytruda boosts RFS in melanoma study
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...
The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with ...
A few years before he took over the U.S. Department of Health and Human Services, Robert F. Kennedy Jr. called COVID-19 shots the "deadliest vaccine ever made." More recently, various anti-vaccination ...
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...
LANSING, Mich. (WLNS) — Canceling federal mRNA vaccine projects threatens much more than pandemic response, according to Michigan State University’s Director of the Precision Health Program, Anna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results